Cytosorbents Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.006583 million compared to USD 0.292634 million a year ago. Revenue was USD 9.42 million compared to USD 8.5 million a year ago. Net loss was USD 6.15 million compared to USD 10.88 million a year ago. Basic loss per share from continuing operations was USD 0.14 compared to USD 0.25 a year ago.
For the six months, sales was USD 0.010353 million compared to USD 0.350226 million a year ago. Revenue was USD 18.87 million compared to USD 17.19 million a year ago. Net loss was USD 13.48 million compared to USD 19.85 million a year ago. Basic loss per share from continuing operations was USD 0.31 compared to USD 0.46 a year ago.